Sagimet Biosciences Other Current Liabilities

Sagimet Biosciences (SGMT) currently reports a other current liabilities of $3M as of March 2026. That compares with $700K in the prior-year period — up 325.2% year over year. Use the charts on this page to explore Sagimet Biosciences's other current liabilities history and peer comparisons.

Sagimet Biosciences's other current liabilities increased from $700K to $3M — a 325.2% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sagimet Biosciences reported $3M in other current liabilities as of March 2026. That compares with $700K in the prior-year period — up 325.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sagimet Biosciences, and consider following SGMT for alerts when major investors trade the stock.